Andrew Goodspeed

1.4k total citations
28 papers, 695 citations indexed

About

Andrew Goodspeed is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Andrew Goodspeed has authored 28 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Andrew Goodspeed's work include Ferroptosis and cancer prognosis (3 papers), Cancer Cells and Metastasis (3 papers) and Acute Myeloid Leukemia Research (3 papers). Andrew Goodspeed is often cited by papers focused on Ferroptosis and cancer prognosis (3 papers), Cancer Cells and Metastasis (3 papers) and Acute Myeloid Leukemia Research (3 papers). Andrew Goodspeed collaborates with scholars based in United States, Japan and Singapore. Andrew Goodspeed's co-authors include James C. Costello, Laura M. Heiser, Joe W. Gray, Annie Jean, Daniel P. Regan, Michael J. Morgan, Andrew Thorburn, Brent E. Fitzwalter, Daniel L. Gustafson and Christina G. Towers and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Andrew Goodspeed

27 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Goodspeed United States 12 378 164 129 110 94 28 695
Diane E. Peters United States 16 294 0.8× 145 0.9× 141 1.1× 170 1.5× 67 0.7× 27 779
Gábor Barna Hungary 15 387 1.0× 108 0.7× 173 1.3× 153 1.4× 48 0.5× 64 711
Patrick Maier Germany 16 417 1.1× 154 0.9× 263 2.0× 111 1.0× 140 1.5× 31 889
Carter J. Barger United States 14 517 1.4× 153 0.9× 171 1.3× 100 0.9× 77 0.8× 22 708
Xiaosheng Fang China 15 300 0.8× 91 0.6× 196 1.5× 123 1.1× 74 0.8× 69 661
Qianshan Ding China 19 526 1.4× 254 1.5× 193 1.5× 146 1.3× 127 1.4× 42 870
Marta Lomnytska Sweden 14 352 0.9× 126 0.8× 120 0.9× 70 0.6× 69 0.7× 21 579
Sanaz Maleki Australia 12 344 0.9× 163 1.0× 162 1.3× 70 0.6× 52 0.6× 15 643
Elena G. Chiorean United States 8 323 0.9× 262 1.6× 143 1.1× 63 0.6× 53 0.6× 18 643
Patrick Bhola United States 11 467 1.2× 139 0.8× 184 1.4× 89 0.8× 108 1.1× 15 820

Countries citing papers authored by Andrew Goodspeed

Since Specialization
Citations

This map shows the geographic impact of Andrew Goodspeed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Goodspeed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Goodspeed more than expected).

Fields of papers citing papers by Andrew Goodspeed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Goodspeed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Goodspeed. The network helps show where Andrew Goodspeed may publish in the future.

Co-authorship network of co-authors of Andrew Goodspeed

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Goodspeed. A scholar is included among the top collaborators of Andrew Goodspeed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Goodspeed. Andrew Goodspeed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giannikou, Krinio, Mikako Warren, Andrew Goodspeed, et al.. (2025). Spatial Profiling Identifies Tumor-Associated Stroma Enrichment and MIF as Potential Immunotherapy Targets in Primary Ewing Sarcomas. Clinical Cancer Research. 31(23). 5051–5069. 1 indexed citations
2.
Spoelstra, Nicole S., et al.. (2025). Androgen Receptors Promote Oxidative Phosphorylation and Resistance to Palmitate Lipotoxicity in ER-Mutant Breast Cancer. Endocrinology. 167(1). 1 indexed citations
3.
4.
Dominici, Marco De, et al.. (2024). Hematopoietic Stem Cell Aging Promotes Expansion of Tet2 Mutant Clones By Cell Intrinsic Mechanisms. Blood. 144(Supplement 1). 191–191. 1 indexed citations
5.
Williams, Michelle M., Jessica L. Christenson, Nicole S. Spoelstra, et al.. (2024). Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity. Cancer Research Communications. 4(10). 2699–2713. 2 indexed citations
6.
Danis, Etienne, Travis Nemkov, Jessica L. Christenson, et al.. (2024). Inflammation Promotes Aging‐Associated Oncogenesis in the Lung. SHILAP Revista de lepidopterología. 6(1). 3–18. 1 indexed citations
7.
Yacob, Betelehem W., John J. Arcaroli, Stacey M. Bagby, et al.. (2024). Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL). PLoS ONE. 19(4). e0298808–e0298808. 3 indexed citations
8.
Mills, Taylor, Bailee Kain, Etienne Danis, et al.. (2024). A distinct metabolic and epigenetic state drives trained immunity in HSC-derived macrophages from autoimmune mice. Cell stem cell. 31(11). 1630–1649.e8. 19 indexed citations
9.
Espinosa, Joaquı́n M., Kelly D. Sullivan, Andrew Goodspeed, et al.. (2023). Down syndrome is associated with altered frequency and functioning of tracheal multiciliated cells, and response to influenza virus infection. iScience. 26(8). 107361–107361. 2 indexed citations
10.
Levey, Daniel L., Dhan Chand, Margaret K. Wilkens, et al.. (2023). Treatment with doxorubicin and PD-1/CTLA-4 blockade improves T cell activation and anti-tumor efficacy in MCA-205 murine fibrosarcoma. The Journal of Immunology. 210(Supplement_1). 63.18–63.18. 2 indexed citations
11.
Goodspeed, Andrew, et al.. (2022). Differential gene expression analysis identified determinants of cell fate plasticity during radiation-induced regeneration in Drosophila. PLoS Genetics. 18(1). e1009989–e1009989. 4 indexed citations
12.
Danis, Etienne, Stephanie Nance, Jenean O’Brien, et al.. (2022). SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state. Cell Reports. 38(5). 110323–110323. 26 indexed citations
13.
Sottnik, Joseph L., et al.. (2021). Mediator of DNA Damage Checkpoint 1 (MDC1) Is a Novel Estrogen Receptor Coregulator in Invasive Lobular Carcinoma of the Breast. Molecular Cancer Research. 19(8). 1270–1282. 9 indexed citations
14.
Higa, Kelly C., Andrew Goodspeed, Marco De Dominici, et al.. (2021). Chronic interleukin-1 exposure triggers selection for Cebpa -knockout multipotent hematopoietic progenitors. The Journal of Experimental Medicine. 218(6). 42 indexed citations
15.
Flores‐Bellver, Miguel, Jason Mighty, Jing Zhou, et al.. (2021). Drusen proteins are released in association with exosomes. Investigative Ophthalmology & Visual Science. 62(8). 2225–2225. 2 indexed citations
16.
Neef, Tobias, Andrew Goodspeed, Brenda Bradley, et al.. (2019). Nanoparticles Containing an Insulin–ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells. The Journal of Immunology. 203(1). 48–57. 58 indexed citations
17.
Towers, Christina G., Brent E. Fitzwalter, Daniel P. Regan, et al.. (2019). Cancer Cells Upregulate NRF2 Signaling to Adapt to Autophagy Inhibition. Developmental Cell. 50(6). 690–703.e6. 76 indexed citations
18.
Goodspeed, Andrew, et al.. (2019). Leveraging the utility of pharmacogenomics in psychiatry through clinical decision support: a focus group study. Annals of General Psychiatry. 18(1). 13–13. 19 indexed citations
19.
Goodspeed, Andrew, Annie Jean, Dan Theodorescu, & James C. Costello. (2018). A Gene Expression Signature Predicts Bladder Cancer Cell Line Sensitivity to EGFR Inhibition. Bladder Cancer. 4(3). 269–282. 8 indexed citations
20.
Agarwal, Neeraj, Garrett M. Dancik, Andrew Goodspeed, et al.. (2016). GON4L Drives Cancer Growth through a YY1–Androgen Receptor–CD24 Axis. Cancer Research. 76(17). 5175–5185. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026